Contract service providers must step up their game to stay competitive in increasingly complex bio/pharma market.

Pharmaceutical Outsourcing Present and Future

The need for preclinical testing expertise is growing as molecular complexity increases.

Navigating the Preclinical CRO Outsourcing Process

A look at the newest innovations offers a deeper understanding of affinity ligands and their role in the future of downstream processing.

A Closer Look at Affinity Ligands

Topic

Angie Drakulich was editorial director of Pharmaceutical Technology.

Articles

As part of the BRIC bloc with Russia, India, and China, Brazil is one of the world's leading emerging economies and is also considered by IMS Health to be one of seven pharmerging nations, which also include Mexico, Turkey, and South Korea.

Global Healthcare on the Ground: Brazil's Development Bank Leader Discusses the Country's Pharma Future

Jim Miller is president of PharmSource Information Services, Inc., and publisher of Bio/Pharmaceutical Outsourcing Report.

Some recent private-equity buyouts of CROs show both the upside and downside for investors.

Contract Services in 2012

Sean Milmo is a freelance writer based in Essex, UK.

The European Union market takes steps toward continuous processing and modular facilities.

Report from Europe

A Q&A with Gilles Cottier, president of SAFC, on recent industry trends.

Q&A with Gilles Cottier, SAFC

Patricia Van Arnum was executive editor of Pharmaceutical Technology.

Expansion activity was limited as fine-chemical producers and CMOs of API and intermediates grapple with changing industry fundamentals.

Contract API Manufacturing: The Year in Review

A dearth of late-stage candidates could hurt the pharmaceutical services market in the future.

Troublesome Signs for Bio/Pharmaceutical R&D

Cleanliness is crucial, even if zapping and trapping is necessary to reduce product contamination.

Buzz Off the Product

Jill Wechsler is Pharmaceutical Technology's Washington Editor, jillwechsler7@gmail.com.

Added responsibilities and outside concerns prompt overhaul of agency's structure.

FDA Revamps to Meet New Challenges

Drug shortages, supply-chain security, generic-drug incursion, and flexible manufacturing models are some of the issues shaping the bio/pharma industry.

Views from Pharma Leaders: A Year in Review and a Look Forward

Jane Wan is a freelance writer based in Singapore.

Packaging is indeed headed to be a lead sector in the Asian pharmaceutical environment, but certain challenges must first be overcome.